Sarissa Capital Management as of March 31, 2020
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 12 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 26.0 | $203M | 643k | 316.38 | |
| Ironwood Pharmaceuticals (IRWD) | 17.4 | $137M | 14M | 10.09 | |
| Alkermes (ALKS) | 13.2 | $104M | 7.2M | 14.42 | |
| Allergan | 10.6 | $83M | 468k | 177.10 | |
| Jazz Pharmaceuticals (JAZZ) | 9.7 | $76M | 765k | 99.74 | |
| Innoviva (INVA) | 9.4 | $73M | 6.2M | 11.76 | |
| Intercept Pharmaceuticals In | 9.3 | $73M | 1.2M | 62.96 | |
| Mersana Therapeutics (MRSN) | 2.8 | $22M | 3.8M | 5.83 | |
| Alexion Pharmaceuticals | 1.5 | $12M | 135k | 89.79 | |
| Regulus Therapeutics | 0.1 | $853k | 1.9M | 0.46 | |
| Abbvie (ABBV) | 0.0 | $76k | 1.0k | 76.00 | |
| Mirati Therapeutics | 0.0 | $76k | 1.0k | 76.00 |
